http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Green Rain Energy Holdings Inc. (OTCID: GREH) Issues Updated Special Dividend Announcement
-
Vycor Medical Releases Financial Results for the Three and Nine Months Ended September 30, 2025
-
U.S. Postal Service Reports Fiscal Year 2025 Results
-
Press Release Biocartis NV: Biocartis Showcases Growing Impact of Idylla™ Platform at AMP 2025
-
Splash Beverage Group launches tequila brand, expands into THC drinks
-
Splash Beverage Group Provides Operational and Strategic Update Following Leadership Transition
-
National University Faculty Named Finalists for 2025 San Diego Business Journal Cybersecurity Stewardship Awards
-
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
BlackRock's BUIDL, Tokenized by Securitize, Now Accepted as Collateral for Trading on Binance and Launches on BNB Chain
-
Walmart names John Furner as next CEO, succeeding Doug McMillon in 2026
-
Walmart names John Furner as CEO to succeed Doug McMillon in 2026
-
Walmart Announces John Furner as President and Chief Executive Officer
-
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference
-
CPI Aerostructures Reports Third Quarter and Nine Month 2025 Results
-
Beyond Lithium announces private placement to raise up to C$600,000
-
Anavex receives negative vote from European regulators on Alzheimer drug
-
Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease
-
Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease
-
Beyond Lithium Announces Flow-Through Private Placement for up to C$600,000 and Provides Rare One Project Update
-
DeFi Technologies reports Q3 revenue of $22.5 million, CEO transition
-
DeFi Technologies Inc. Announces Q3 2025 Financial Results: Revenues of $22.5 million, Operating Income of $9 million, and CEO Transition
-
Ionis' DAWNZERA receives EU regulatory committee recommendation for HAE
-
Scholar Rock Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Erdene Files Updated Resource for the Zuun Mod Molybdenum-Copper Project
-
DAWNZERA™ (donidalorsen) receives positive opinion from CHMP, recommended for approval in EU for hereditary angioedema (HAE)
-
Merck to acquire Cidara for $9.2 billion to gain influenza drug
-
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
-
Bitget Partners with Tiger.com, Bringing High-Speed Tools to Intraday Traders
-
Discover the Adorable World of Sanrio Characters
-
Bitget Sees Uptick in VIP Demand for Yield Strategies
-
Artmarket.com news: Artprice launches Artprice News, the world's first news agency entirely dedicated to art and its market, available in 11 languages and 122 countries, with Cision PR Newswire and Pe
-
Voting Rights and Shares Capital of the Company
-
Searching for the Best Crypto Presale? A Deep Dive into Projects with 1000x Potential
-
FRONTERA ANNOUNCES STRATEGIC SPIN-OFF OF ITS COLOMBIAN INFRASTRUCTURE BUSINESS TO UNLOCK INTRINSIC VALUE
-
FRONTERA ANNOUNCES THIRD QUARTER 2025 RESULTS
-
Top Altcoin Picks: Bitcoin ETF Inflows Hit $524M, Solana Slips, Chainlink Pops, and Apeing Becomes the Degen Favorite
-
QSE Group – a Scope Technologies Division Collaborates with Enzo Plus to Accelerate Quantum Security Adoption Across Southeast Asia
-
Ainos Reports Third Quarter 2025 Financial Results
-
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
-
Capstone Green Energy Delivers Continued Profitability and Margin Expansion in Second Quarter Fiscal 2026
-
Cartesian reports positive SLE trial results, expands into myositis
-
Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis
-
Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
BioStem Technologies files restated financial statements
-
Rekor Systems Reports Record Third Quarter 2025 Financial Results
-
BioStem Technologies Reports Third Quarter 2025 Financial Results
-
BioStem Technologies Announces Filing of Restated Financial Statements
-
Tvardi Therapeutics Announces Third Quarter 2025 Results and Provides Business Update
-
Daré Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
$78 Million Awarded to Replace 286 Polluting School Buses with Cleaner Models
